Analyst Research

Report Title Price
Provider : Stock Traders Daily
Provider : Thomson Reuters Stock Report
Provider : Ford Investor Services, Inc.
Provider : Jefferson Research

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sagent Pharmaceuticals Inc raises low end prior FY 2014 guidance to range in line with analysts' estimates

Wednesday, 30 Jul 2014 07:00am EDT 

Sagent Pharmaceuticals Inc:Narrows FY 2014 net revenue and earnings guidance to the upper end of initial range.Anticipates FY 2014 net revenue for the year to be in the range of $270 to $290 million.Anticipates reported net income for FY 2014 to be in the range of breakeven to $10 million in earnings.FY 2014 revenue of $279 million and net income of $6 million - Thomson Reuters I/B/E/S. 

Company Quote

0.93 +6.23%
2 Oct 2015